Arcturus Therapeutics Holdings Inc.
USD6.85
+0.03 (+0.44%)
CEO
Joseph E. Payne
IPO Date
2013-05-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.86
Prev. Close
$6.82
Day Low
$6.71
Day High
$6.99
52W Low
$5.85
52W High
$24.17
Market Cap
$0.19B
Volume
0.08M
| -5.7 |
| 31 Dec 2023 | FY | 100.0% | -18.8% | -10.7% | -6.9% | 0.11 | 4.72 | -28.2 |
| 31 Dec 2022 | FY | 100.0% | 4.5% | 3.5% | 2.1% | 0.35 | 3.18 | 48.0 |
| 31 Dec 2021 | FY | 100.0% | -1648.0% | -89.2% | -51.8% | 0.30 | 3.81 | -4.8 |
| 31 Dec 2020 | FY | -486.5% | -756.3% | -18.2% | -15.1% | 0.05 | 9.45 | -12.2 |
| 31 Dec 2019 | FY | 100.0% | -125.0% | -100.8% | -31.6% | 0.80 | 3.48 | -5.0 |
| 31 Dec 2018 | FY | -7.8% | -138.3% | -159.7% | -49.3% | 0.73 | 3.33 | -2.1 |
| 31 Dec 2017 | FY | 96.8% | -83.9% | -32.3% | -21.0% | 0.00 | 4.61 | -2.3 |
| 31 Dec 2016 | FY | 98.6% | -120.7% | -52.1% | -47.7% | 0.00 | 11.82 | -2.4 |
| -1.4 |
| 30 Sept 2025 | Q3 | 80.5% | -78.4% | -6.0% | -4.8% | 0.10 | 7.86 | -9.3 |
| 30 Jun 2025 | Q2 | 100.0% | -37.5% | -4.0% | -3.0% | 0.12 | 5.90 | -9.6 |
| 31 Mar 2025 | Q1 | 100.0% | -47.9% | -6.0% | -4.2% | 0.18 | 5.64 | -5.1 |
| 31 Dec 2024 | Q4 | 100.0% | -142.9% | -12.5% | -8.7% | 0.12 | 4.67 | -3.8 |
| 30 Sept 2024 | Q3 | 100.0% | -17.8% | -2.6% | -1.9% | 0.11 | 4.76 | -22.7 |
| 30 Jun 2024 | Q2 | 100.0% | -37.4% | -6.7% | -4.4% | 0.12 | 3.78 | -9.3 |
| 31 Mar 2024 | Q1 | 100.0% | -82.3% | -10.2% | -6.4% | 0.12 | 3.26 | -8.3 |
| 31 Dec 2023 | Q4 | 100.0% | -46.7% | -4.2% | -2.7% | 0.11 | 4.72 | -17.9 |